pyridostigmine bromide has been researched along with Obesity in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 18 (81.82) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camanni, F; Cavagnini, F; Ghigo, E; Grottoli, S; Invitti, C; Maccario, M; Procopio, M | 1 |
| Bento, A; Dieguez, C; Mota, A; Peñalva, A; Pombo, M | 1 |
| Casanueva, FF; Cordido, F; Dieguez, C; Peino, R; Peñalva, A | 1 |
| Huh, KB; Kim, KR; Lee, DJ; Lee, EJ; Lee, HC; Lee, JH; Lee, KM; Lim, SK | 1 |
| Bresciani, E; Girelli, A; Giustina, A; Tassi, C; Valentini, U | 1 |
| Conte, G; De Marinis, L; Fabrizi, ML; Fiumara, C; Iacona, T; Mancini, A; Sammartano, L; Valle, D | 1 |
| Bellone, J; Benedetti, S; Borrelli, P; Cappa, M; Carta, D; Ghigo, E; Grossi, A; Loche, S | 1 |
| Bowers, CY | 1 |
| Casanueva, FF; Cordido, F; Dieguez, C; Peñalva, A | 1 |
| Bigos, ST; Bing-You, RG; Oppenheim, DS | 1 |
| Alvarez, CV; Casanueva, FF; Cordido, F; Dieguez, C; Peino, R; Peñalva, A | 1 |
| Bondi, M; Del Rio, G; Ghigo, E; Grottoli, S; Maccario, M; Marrama, P; Menozzi, R; Oleandri, SE; Procopio, M; Velardo, A | 1 |
| Aimaretti, G; Arvat, E; Baffoni, C; Camanni, F; Ghigo, E; Grottoli, S; Maccario, M; Oleandri, SE; Procopio, M; Savio, P; Tassone, F; Valetto, MR | 1 |
| Bettio, D; De Medici, C; Grugni, G; Guzzaloni, G; Morabito, F; Moro, D | 1 |
| Grugni, G; Guzzaloni, G; Morabito, F | 1 |
| Calabrò, F; De Marinis, L; Fabrizi, ML; Fiumara, C; Lagonigro, G; Mancini, A; Sammartano, L; Zuppi, P | 1 |
| Casanueva, FF; Cordido, F; Diéguez, C; Morales, MJ; Muruais, C | 1 |
| Besser, GM; Castro, RC; Chacra, AR; Grossman, AB; Lengyel, AM; Vieira, JG | 1 |
| Casanueva, FF; Cordido, F; Dieguez, C | 2 |
| Cappa, M; Ghigo, E; Locatelli, V; Loche, S; Müller, EE; Pintor, C; Puggioni, R | 1 |
| Arvat, E; Bellone, J; Camanni, F; Corrias, A; De Sanctis, C; Ghigo, E; Goffi, S; Imperiale, E; Mazza, E; Müller, EE | 1 |
6 trial(s) available for pyridostigmine bromide and Obesity
| Article | Year |
|---|---|
Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Topics: Adolescent; Adult; Arginine; Case-Control Studies; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Middle Aged; Obesity; Pyridostigmine Bromide | 1995 |
Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
Topics: Adult; Body Mass Index; Cross-Over Studies; Fatty Acids, Nonesterified; Growth Hormone; Humans; Insulin; Levodopa; Male; Obesity; Pituitary Gland; Pyridostigmine Bromide | 1994 |
Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Synergism; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Male; Middle Aged; Obesity; Pyridostigmine Bromide; Reference Values | 1994 |
Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
Topics: Adolescent; Adult; Fatty Acids, Nonesterified; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypolipidemic Agents; Male; Middle Aged; Obesity; Oligopeptides; Pyrazines; Pyridostigmine Bromide | 1996 |
Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
Topics: Abdomen; Adult; Blood Glucose; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Obesity; Pyridostigmine Bromide; Time Factors | 1997 |
Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Topics: Adolescent; Adult; Biotransformation; Child; Cholinergic Antagonists; Drug Synergism; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamus; Male; Middle Aged; Obesity; Pyridostigmine Bromide; Receptors, Cholinergic | 1989 |
16 other study(ies) available for pyridostigmine bromide and Obesity
| Article | Year |
|---|---|
Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Topics: Arginine; Child; Clonidine; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Obesity; Pituitary Gland, Anterior; Prolactin; Pyridostigmine Bromide; Receptors, Serotonin; Sumatriptan; Thyrotropin; Thyrotropin-Releasing Hormone | 1995 |
Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects.
Topics: Adult; Drug Combinations; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Obesity; Oligopeptides; Pyridostigmine Bromide; Reference Values | 1995 |
Pyridostigmine effects on TSH response to TRH in adult and children obese subjects.
Topics: Adolescent; Adult; Child; Drug Interactions; Female; Humans; Kinetics; Male; Obesity; Pyridostigmine Bromide; Thyrotropin; Thyrotropin-Releasing Hormone | 1993 |
Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Obesity; Prader-Willi Syndrome; Pyridostigmine Bromide | 1993 |
A new dimension on the induced release of growth hormone in obese subjects.
Topics: Drug Combinations; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Obesity; Oligopeptides; Pyridostigmine Bromide | 1993 |
Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
Topics: Adolescent; Adult; Drug Combinations; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Injections, Intravenous; Male; Middle Aged; Obesity; Oligopeptides; Pituitary Gland, Anterior; Pyridostigmine Bromide | 1993 |
Serum growth hormone response to growth hormone-releasing hormone in non-obese and obese adults with hypopituitarism.
Topics: Adult; Aged; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypopituitarism; Male; Middle Aged; Obesity; Pituitary Gland; Pyridostigmine Bromide | 1993 |
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Topics: Adult; Arginine; Case-Control Studies; Cushing Syndrome; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Male; Middle Aged; Obesity; Pyridostigmine Bromide | 1998 |
Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
Topics: Adolescent; Adult; Child; Cholinesterase Inhibitors; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Obesity; Prader-Willi Syndrome; Pyridostigmine Bromide | 1998 |
Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
Topics: Adolescent; Adult; Body Mass Index; Child; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Kinetics; Male; Obesity; Oligopeptides; Prader-Willi Syndrome; Pyridostigmine Bromide | 2001 |
Influence of pyridostigmine on growth hormone (GH) response to GH-releasing hormone pre- and postprandially in normal and obese subjects.
Topics: Adult; Drug Interactions; Eating; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Male; Obesity; Pyridostigmine Bromide; Reference Values; Time Factors | 1992 |
Corticosteroid-induced growth hormone secretion in normal and obese subjects.
Topics: Adrenal Cortex Hormones; Adult; Dexamethasone; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Male; Obesity; Pregnenediones; Pyridostigmine Bromide; Stimulation, Chemical; Time Factors | 1991 |
Pyridostigmine enhances, but does not normalise, the GH response to GH-releasing hormone in obese subjects.
Topics: Adolescent; Adult; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Obesity; Pyridostigmine Bromide | 1990 |
Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Topics: Adolescent; Adult; Arginine; Child; Cholinergic Fibers; Clonidine; Drug Interactions; Female; Growth Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Middle Aged; Obesity; Prolactin; Pyridostigmine Bromide; Synaptic Transmission; Thyrotropin; Thyrotropin-Releasing Hormone | 1990 |
Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children.
Topics: Adolescent; Child; Child, Preschool; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Obesity; Obesity, Morbid; Pyridostigmine Bromide; Receptors, Cholinergic | 1989 |
Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children.
Topics: Adult; Age Factors; Child; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Obesity; Pyridostigmine Bromide; Reference Values | 1989 |